Historical record - last NADAC effective date: 8/17/2016
Product Information
SIMVASTATIN 10 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.0269 per EA under NDC 42571001005. Its NADAC has been published 107 times since Aug 20, 2014.
FDA first approved this application on Sep 16, 2011.
Strength
10 mg/1
Manufacturer
Micro Labs LimitedNDC
42571001005
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/17/2016
Active Ingredients
SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA090383FDA Approved
9/16/2011
On Market Since
6/13/2013
Pharmacological Classes
Price Statistics
The NADAC for SIMVASTATIN 10 MG TABLET has been published 107 times since Aug 20, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0269 per EA |
|---|---|
| All-time high | $0.0325 (Dec 10, 2014) |
| All-time low | $0.0231 (May 18, 2016) |
| Median price | $0.0265 |
| Average price | $0.0269 |
| Largest weekly change | +30.8% (Nov 19, 2014) |
| Weeks tracked | 107 |
| Tracking since | Aug 20, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+0.9%
Last surveyed Aug 31, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SIMVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 10 MG TABLET, manufactured by Micro Labs Limited, is $0.0269 per EA (NDC 42571001005), effective Aug 31, 2016.
How has the price of SIMVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIMVASTATIN 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 107 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for SIMVASTATIN 10 MG TABLET?
Since Aug 20, 2014, the NADAC for SIMVASTATIN 10 MG TABLET has ranged from a low of $0.0231 (May 18, 2016) to a high of $0.0325 (Dec 10, 2014), with a median of $0.0265 per EA.
Are there cheaper alternatives to SIMVASTATIN 10 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 10 MG TABLET, is $0.0261 per EA — about 3% below SIMVASTATIN 10 MG TABLET.
Who manufactures SIMVASTATIN 10 MG TABLET?
SIMVASTATIN 10 MG TABLET (NDC 42571001005) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.